Digital Breast Tomosynthesis Market Overview
Digital Breast Tomosynthesis Market size is estimated at $2.8 billion in 2021, projected to grow at a CAGR of 13.2% during the forecast period 2022-2027. Digital Breast Tomosynthesis (DBT) is a kind of breast imaging, or mammography, which converts x-ray images of the breast into a three-dimensional image set using low-dose x-ray equipment, electronics, and a computer. It's used to provide high-resolution limited-angle tomography at radiation doses comparable to protection radiography and for detecting and diagnosing cancer at an early stage. Projectional radiography or conventional radiography produces two-dimensional images by x-ray radiations. DBT is also known as 3d mammography. According to German research published in October 2021 in European Radiology, when compared to conventional mammography alone, combining digital breast tomosynthesis (DBT) with synthesized 2D mammography results in greater cancer detection rates with fewer recalls. Synthetic mammography uses DBT data to recreate 2D images, requiring no additional radiation. Image quality is key to early detection. Hologic's, a medical technology company primarily focused on women’s health, direct conversion detector is used in the Selenia Dimensions Hologic, eliminating the need to convert x-rays to light. As a result, the digital images are exceedingly sharp and have a high Detective Quantum Efficiency (DQE), allowing for low-dose tomosynthesis imaging.
Increasing prevalence of breast cancer, technological advancements for the detection and diagnosis of cancer and growing awareness about the benefits of tomosynthesis are some of the factors driving the Digital Breast Tomosynthesis industry forward in the projected period of 2022-2027.
The report: “Digital Breast Tomosynthesis Market Forecast (2022-2027)", by Industry ARC covers an in-depth analysis of the following segments of the Digital Breast Tomosynthesis Market.
By Product Type- 2D/3D Combination Mammography Systems and Standalone 3D Mammography Systems
By End-User- Hospitals, Diagnostic Centers, and Others
By Geography- North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (the Middle East, and Africa).
- Geographically, North America held a dominant market share in the year 2021 owing to the increasing prevalence of breast cancer cases and developed healthcare infrastructure. Additionally, Asia-Pacific is expected to offer lucrative growth opportunities to the marketers owing to rising healthcare expenditure and increasing awareness about Digital Breast Tomosynthesis. The robust growth in the end-use industries such as hospitals and diagnostic centers are some of the factors driving the market growth.
- The increasing prevalence of breast cancer globally and technological advancements is predicted to augment the market growth during the forecast period of 2022-2027. Hugh operation and installation cost accompanied with the risk of harmful radiations continues to pose threat to the market growth.
- A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Digital Breast Tomosynthesis Market Report.